Claudin 1 in breast tumorigenesis: Revelation of a possible novel "claudin high" subset of breast cancers

Journal of Biomedicine and Biotechnology

Volumn 2010, Issue , 2010, Pages

  Myal, Yvonne ^a   Leygue, Etienne ^a   Blanchard, Anne A ^a  

^a UNIVERSITY OF MANITOBA   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

CLAUDIN 1; EPIDERMAL GROWTH FACTOR RECEPTOR; ESTROGEN RECEPTOR; GELATINASE A; ION CHANNEL; UVOMORULIN; ESTROGEN; MEMBRANE PROTEIN;

BREAST CANCER; BREAST CARCINOGENESIS; CANCER CELL CULTURE; CANCER GROWTH; CANCER INVASION; CANCER LOCALIZATION; CANCER RECURRENCE; CELL INTERACTION; CELL MOTILITY; CELL POLARITY; DISEASE FREE SURVIVAL; ENZYME ACTIVATION; EPITHELIAL MESENCHYMAL TRANSITION; EPITHELIUM CELL; HUMAN; METASTASIS; NONHUMAN; PHENOTYPE; PROTEIN ANALYSIS; PROTEIN EXPRESSION; PROTEIN FUNCTION; REVIEW; TIGHT JUNCTION; TISSUE SPECIFICITY; TUMOR SUPPRESSOR GENE; ARTICLE; BREAST TUMOR; DISEASE COURSE; FEMALE; METABOLISM; PATHOLOGY; TUMOR CELL LINE;

BREAST NEOPLASMS; CELL LINE, TUMOR; DISEASE PROGRESSION; ESTROGENS; FEMALE; HUMANS; MEMBRANE PROTEINS; NEOPLASM INVASIVENESS; NEOPLASM METASTASIS; PHENOTYPE; RECEPTORS, ESTROGEN; TIGHT JUNCTIONS;

EID: 77953528155     PISSN: 11107243     EISSN: 11107251     Source Type: Journal    
DOI: 10.1155/2010/956897     Document Type: Review

References (83)

1. Canadian Cancer Statistics. 2006, http://www.cancer.ca/
2. Allred D. C., Wu Y., Mao S., Ductal carcinoma in situ and the emergence of diversity during breast cancer evolution Clinical Cancer Research 2008 14 2 370 378
3. Hu M., Yao J., Carroll D. K., Regulation of in situ to invasive breast carcinoma transition Cancer Cell 2008 13 5 394 406
4. Simpson P. T., Reis-Filho J. S., Gale T., Lakhani S. R., Molecular evolution of breat cancer Journal of Pathology 2005 205 2 248 254
5. Finak G., Sadekova S., Pepin F., Gene expression signatures of morphologically normal breast tissue identify basal-like tumors Breast Cancer Research 2006 8, article R58
6. Kwan M. L., Kushi L. H., Weltzien E., Epidemiology of breast cancer subtypes in two prospective cohort studies of breast cancer survivors Breast Cancer Research 2009 11, article R31
7. Nielsen T. O., Hsu F. D., Jensen K., Immunohistochemical and clinical characterization of the basal-like subtype of invasive breast carcinoma Clinical Cancer Research 2004 10 16 5367 5374
8. Perou C. M., Sorlie T., Eisen M. B., Molecular portraits of human breast tumours Nature 2000 406 6797 747 752
9. Sorlie T., Tibshirani R., Parker J., Repeated observation of breast tumor subtypes in independent gene expression data sets Proceedings of the National Academy of Sciences of USA 2003 100 8418 8423
10. Yu K.-D., Shen Z.-Z., Shao Z.-M., The immunohistochemically eR-negative, PR-negative, HER2-negative, CK5/6-negative, and HER1-negative subgroup is not a surrogate for the normal-like subtype in breast cancer Breast Cancer Research and Treatment 2009 118 3 661 663
11. Bild A. H., Parker J. S., Gustafson A. M., An integration of complementary strategies for gene-expression analysis to reveal novel therapeutic opportunities for breast cancer Breast Cancer Research 2009 11, article R55
12. Hugh J., Hanson J., Cheang M. C. U., Breast cancer subtypes and response to docetaxel in node-positive breast cancer: use of an immunohistochemical definition in the BCIRG 001 trial Journal of Clinical Oncology 2009 27 8 1168 1176
13. Nicholson R. I., Johnston S. R., Endocrine therapycurrent benefits and limitations Breast Cancer Research and Treatment 2005 93 supplement 1 S3 S10
14. Rakha E. A., Elsheikh S. E., Aleskandarany M. A., Triple-negative breast cancer: distinguishing between basal and nonbasal subtypes Clinical Cancer Research 2009 15 7 2302 2310
15. Vargo-Gogola T., Rosen J. M., Modelling breast cancer: one size does not fit all Nature Reviews Cancer 2007 7 9 659 672
16. Kao J., Salari K., Bocanegra M., Molecular profiling of breast cancer cell lines defines relevant tumor models and provides a resource for cancer gene discovery PLoS ONE 2009 4 7, article e6146
17. Rakha E. A., Ellis I. O., Triple-negative/basal-like breast cancer: review Pathology 2009 41 1 40 47
18. Polyak K., Breast cancer: origins and evolution Journal of Clinical Investigation 2007 117 11 3155 3163
19. Jeselsohn R., Brown N. E., Arendt L., Cyclin D1 kinase activity is required for the self-renewal of mammary stem and progenitor cells that are targets of MMTV-ErbB2 tumorigenesis Cancer Cell 2010 17 1 65 76
20. Guarino M., Rubino B., Ballabio G., The role of epithelial-mesenchymal transition in cancer pathology Pathology 2007 39 3 305 318
21. Kokkinos M. I., Wafai R., Wong M. K., Newgreen D. F., Thompson E. W., Waltham M., Vimentin and epithelial-mesenchymal transition in human breast cancerobservations in vitro and in vivo Cells Tissues Organs 2007 185 13 191 203
22. Boyer B., Valles A. M., Edme N., Induction and regulation of epithelial-mesenchymal transitions Biochemical Pharmacology 2000 60 8 1091 1099
23. Hay E. D., An overview of epithelio-mesenchymal transformation Acta Anatomica 1995 154 1 8 20
24. Mareel M., Leroy A., Clinical, cellular, and molecular aspects of cancer invasion Physiological Reviews 2003 83 2 337 376
25. Mullin J. M., Potential interplay between luminal growth factors and increased tight junction permeability in epithelial carcinogenesis Journal of Experimental Zoology 1997 279 5 484 489
26. Tsukita S., Furuse M., Itoh M., Multifunctional strands in tight junctions Nature Reviews Molecular Cell Biology 2001 2 4 285 293
27. Gonzales-Mariscal L., Tight Junctions 2001 2nd Boca Raton, Fla, USA CRC Press
28. Diamond J. M., Twenty-first Bowditch lecture. The epithelial junction: bridge, gate, and fence. Physiologist 1977 20 1 10 18
29. Tobioka H., Isomura H., Kokai Y., Tokunaga Y., Yamaguchi J., Sawada N., Occludin expression decreases with the progression of human endometrial carcinoma Human Pathology 2004 35 2 159 164
30. Eaton S., Simons K., Apical, basal, and lateral cues for epithelial polarization Cell 1995 82 1 5 8
31. Gumbiner B., Structure, biochemistry, and assembly of epithelial tight junctions American Journal of Physiology 1987 253 6 C749 C758
32. Itoh M., Bissell M. J., The organization of tight junctions in epithelia: implications for mammary gland biology and breast tumorigenesis Journal of Mammary Gland Biology and Neoplasia 2003 8 449 462
33. Morin P. J., Claudin proteins in human cancer: promising new targets for diagnosis and therapy Cancer Research 2005 65 21 9603 9606
34. Simons K., Fuller S. D., Cell surface polarity in epithelia Annual Review of Cell Biology 1985 1 243 288
35. Tsukita S., Furuse M., Claudin-based barrier in simple and stratified cellular sheets Current Opinion in Cell Biology 2002 14 5 531 536
36. Andersen J. M., Balda M. S., Fanning A. S., The structure and regulation of tight junctions Current Opinion in Cell Biology 1993 5 5 772 778
37. Mitic L. L., Anderson J. M., Molecular architecture of tight junctions Annual Review of Physiology 1998 60 121 142
38. Farquhar M. G., Palade G. E., Junctional complexes in various epithelia The Journal of Cell Biology 1963 17 375 412
39. Hoover K. B., Liao S.-Y., Bryant P. J., Loss of the tight junction MAGUK ZO-1 in breast cancer: relationship to glandular differentiation and loss of heterozygosity American Journal of Pathology 1998 153 6 1767 1773
40. Polak-Charcon S., Shoham J., Ben-Shaul Y., Tight junctions in epithelial cells of human fetal hindgut, normal colon, and colon adenocarcinoma Journal of the National Cancer Institute 1980 65 1 53 62
41. Soler A. P., Miller R. D., Laughlin K. V., Carp N. Z., Klurfeld D. M., Mullin J. M., Increased tight junctional permeability is associated with the development of colon cancer Carcinogenesis 1999 20 8 1425 1431
42. Kaihara T., Kawamata H., Imura J., Redifferentiation and ZO-1 reexpression in liver-metastasized colorectal cancer: possible association with epidermal growth factor receptor-induced tyrosine phosphorylation of ZO-1 Cancer Science 2003 94 2 166 172
43. National Center for Biotechnology Information,. 2009, http://www.ncbi.nlm.nih.gov/gene
44. European Bioinformatics Institute,. 2009, http://www.ebi.ac.uk/embl/
45. Bishop J. O., Clark A. J., Clissold P. M., Hainey S., Francke U., Two main groups of mouse major urinary protein genes, both largely located on chromosome 4 The EMBO Journal 1982 1 5 615 620
46. Hood L., Steinmetz M., Goodenow R., Genes of the major histocompatibility complex Cell 1982 28 4 685 687 (Pubitemid 12084324)
47. Tokes A. M., Kulka J., Paku S., Claudin-1, -3 and -4 proteins and mRNA expression in benign and malignant breast lesions: a research study Breast Cancer Research 2005 7 2 R296 R305
48. Loh Y. H., Christoffels A., Brenner S., Hunziker W., Venkatesh B., Extensive expansion of the claudin gene family in the teleost fish, Fugu rubripes Genome Research 2004 14 7 1248 1257
49. Tsukita S., Furuse M., Occludin and claudins in tight-junction strands: leading or supporting players? Trends in Cell Biology 1999 9 268 273
50. The Cancer Genome Anatomy Project,. 2009, http://cgap.nci.nih.gov/
51. Morita K., Furuse M., Fujimoto K., Tsukita S., Claudin multigene family encoding four-transmembrane domain protein components of tight junction strands Proceedings of the National Academy of Sciences of the United States of America 1999 96 2 511 516
52. Hoevel T., Macek R., Mundigl O., Swisshelm K., Kubbies M., Expression and targeting of the tight junction protein CLDN1 in CLDN1-negative human breast tumor cells Journal of Cellular Physiology 2002 191 1 60 68
53. Kramer F., White K., Kubbies M., Swisshelm K., Weber B. H. F., Genomic organization of claudin-1 and its assessment in hereditary and sporadic breast cancer Human Genetics 2000 107 3 249 256
54. Kominsky S. L., Argani P., Korz D., Loss of the tight junction protein claudin-7 correlates with histological grade in both ductal carcinoma in situ and invasive ductal carcinoma of the breast Oncogene 2003 22 13 2021 2033
55. Furuse M., Hata M., Furuse K., Claudin-based tight junctions are crucial for the mammalian epidermal barrier: a lesson from claudin-1-deficient mice Journal of Cell Biology 2002 156 6 1099 1111
56. Hewitt K. J., Agarwal R., Morin P. J., The claudin gene family: expression in normal and neoplastic tissues BMC Cancer 2006 6, article 186
57. Sheehan G. M., Kallakury B. V. S., Sheehan C. E., Fisher H. A. G., Kaufman Jr. R. P., Ross J. S., Loss of claudins-1 and -7 and expression of claudins-3 and -4 correlate with prognostic variables in prostatic adenocarcinomas Human Pathology 2007 38 4 564 569
58. Swisshelm K., Macek R., Kubbies M., Role of claudins in tumorigenesis Advanced Drug Delivery Reviews 2005 57 6 919 928
59. Cohn M. L., Goncharuk V. N., Diwan A. H., Zhang P. S., Shen S. S., Prieto V. G., Loss of claudin-1 expression in tumor-associated vessels correlates with acquisition of metastatic phenotype in melanocytic neoplasms Journal of Cutaneous Pathology 2005 32 8 533 536
60. Miyamoto K., Kusumi T., Sato F., Decreased expression of claudin-1 is correlated with recurrence status in esophageal squamous cell carcinoma Biomedical Research 2008 29 2 71 76
61. Chao Y.-C., Pan S.-H., Yang S.-C., Claudin-1 is a metastasis suppressor and correlates with clinical outcome in lung adenocarcinoma American Journal of Respiratory and Critical Care Medicine 2009 179 2 123 133
62. Nemeth J., Nemeth Z., Tatrai P., High expression of claudin-1 protein in papillary thyroid tumor and its regional lymph node metastasis Pathology Oncology Research 2009 16 1 19 27
63. Oku N., Sasabe E., Ueta E., Yamamoto T., Osaki T., Tight junction protein claudin-1 enhances the invasive activity of oral squamous cell carcinoma cells by promoting cleavage of laminin-5 2 chain via matrix metalloproteinase (MMP)-2 and membrane-type MMP-1 Cancer Research 2006 66 10 5251 5257
64. Kleinberg L., Holth A., Trope C. G., Reich R., Davidson B., Claudin upregulation in ovarian carcinoma effusions is associated with poor survival Human Pathology 2008 39 5 747 757
65. Dhawan P., Singh A. B., Deane N. G., Claudin-1 regulates cellular transformation and metastatic behavior in colon cancer Journal of Clinical Investigation 2005 115 7 1765 1776
66. Resnick M. B., Konkin T., Routhier J., Sabo E., Pricolo V. E., Claudin-1 is a strong prognostic indicator in stage II colonic cancer: a tissue microarray study Modern Pathology 2005 18 4 511 518
67. Leotlela P. D., Wade M. S., Duray P. H., Claudin-1 overexpression in melanoma is regulated by PKC and contributes to melanoma cell motility Oncogene 2007 26 26 3846 3856
68. Wu Y.-L., Zhang S., Wang G.-R., Chen Y.-P., Expression transformation of claudin-1 in the process of gastric adenocarcinoma invasion World Journal of Gastroenterology 2008 14 31 4943 4948
69. Miyamori H., Takino T., Kobayashi Y., Claudin promotes activation of pro-matrix metalloproteinase-2 mediated by membrane-type matrix metalloproteinases Journal of Biological Chemistry 2001 276 30 28204 28211
70. Blanchard A., Shiu R., Booth S., Gene expression profiling of early involuting mammary gland reveals novel genes potentially relevant to human breast cancer Frontiers in Bioscience 2007 12 2221 2232
71. Blanchard A. A. A., Watson P. H., Shiu R. P. C., Differential expression of claudin 1, 3, and 4 during normal mammary gland development in the mouse DNA and Cell Biology 2006 25 2 79 86
72. Swisshelm K., Machl A., Planitzer S., Robertson R., Kubbies M., Hosier S., SEMP1, a senescence-associated cDNA isolated from human mammary epithelial cells, is a member of an epithelial membrane protein superfamily Gene 1999 226 2 285 295
73. Morohashi S., Kusumi T., Sato F., Decreased expression of claudin-1 correlates with recurrence status in breast cancer International Journal of Molecular Medicine 2007 20 2 139 143
74. Kulawiec M., Safina A., Desouki M. M., Tumorigenic transformation of human breast epithelial cells induced by mitochondrial DNA depletion Cancer Biology and Therapy 2008 7 11 1732 1743
75. Hoevel T., Macek R., Swisshelm K., Kubbies M., Reexpression of the TJ protein CLDN1 induces apoptosis in breast tumor spheroids International Journal of Cancer 2004 108 3 374 383
76. Blanchard A. A., Skliris G. P., Watson P. H., Claudins 1, 3, and 4 protein expression in ER negative breast cancer correlates with markers of the basal phenotype Virchows Archiv 2009 454 6 647 656
77. Soini Y., Tommola S., Helin H., Martikainen P., Claudins 1, 3, 4 and 5 in gastric carcinoma, loss of claudin expression associates with the diffuse subtype Virchows Archiv 2006 448 1 52 58
78. Bolos V., Peinado H., Perez-Moreno M. A., Fraga M. F., Esteller M., Cano A., The transcription factor Slug represses E-cadherin expression and induces epithelial to mesenchymal transitions: a comparison with Snail and E47 repressors Journal of Cell Science 2003 116 3 499 511
79. Hajra K. M., Chen D. Y., Fearon E. R., The SLUG zinc-finger protein represses E-cadherin in breast cancer Cancer Research 2002 62 6 1613 1618
80. Martinez-Estrada O. M., Culleres A., Soriano F. X., The transcription factors Slug and Snail act as repressors of claudin-1 expression in epithelial cells Biochemical Journal 2006 394 2 449 457
81. Kulka J., Szasz A. M., Nemeth Z., Expression of tight junction protein Claudin-4 in basal-like breast carcinomas Pathology and Oncology Research 2009 15 1 59 64
82. Tay P. N., Lan Y., Leung C. H., Hooi S. C., Genes associated with metastasis and epithelial-mesenchymal transition (EMT)-like phenotype in human colon cancer cells: palladin in colon cancer metastasis Proceedings of the 99th Annual Meeting of the American Association for Cancer Research (AACR '08) April 2008 San Diego, Calif, USA. abstract no. 5361
83. Herschkowitz J. I., Simin K., Weigman V. J., Identification of conserved gene expression features between murine mammary carcinoma models and human breast tumors Genome Biology 2007 8, article R76